Evidence map›Paper›PMID 32235931›Full record

ArticleScientific reports2020

The Extracellular Domain of Two-component System Sensor Kinase VanS from Streptomyces coelicolor Binds Vancomycin at a Newly Identified Binding Site.

Christine Lockey, Richard J Edwards, David I Roper, Ann M Dixon

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Two-Component Systems ofInternational journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christine LockeyMOAC Doctoral Training Centre, University of Warwick, Coventry, CV4 7AL, UK.
Richard J EdwardsMedical Research Council Doctoral Training Centre, University of Warwick, Coventry, CV4 7AL, UK.
David I RoperSchool of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.
Ann M DixonDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK. ann.dixon@warwick.ac.uk.
University of Warwick · GB

Funding

Medical Research Council G0500643Medical Research Council G0701400Medical Research Council G0900208-1/1Medical Research Council MR/P022995/1
6 · The paper itself

Abstract

The glycopeptide antibiotic vancomycin has been widely used to treat infections of Gram-positive bacteria including Clostridium difficile and methicillin-resistant Staphylococcus aureus. However, since its introduction, high level vancomycin resistance has emerged. The genes responsible require the action of the two-component regulatory system VanSR to induce expression of resistance genes. The mechanism of detection of vancomycin by this two-component system has yet to be elucidated. Diverging evidence in the literature supports activation models in which the VanS protein binds either vancomycin, or Lipid II, to induce resistance. Here we investigated the interaction between vancomycin and VanS from Streptomyces coelicolor (VanS

Indexed as

Bacterial ProteinsBinding SitesGene Expression Regulation, BacterialStreptomyces coelicolorTranscription FactorsVancomycinVancomycin ResistanceBacterial ProteinsTranscription FactorsVancomycin

Identifiers

PMID32235931
PMCPMC7109055
OpenAlexW3014159436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.